Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | FERMT1 |
| Upstream (Parents) |
|---|
| (<<) ARHGEF4 → FERMT1 |
| (<<) CCNA1 → FERMT1 |
| (<<) CCNE1 → FERMT1 |
| (<<) CDH3 → FERMT1 |
| (<<) CHST3 → FERMT1 |
| (<<) CRYAB → FERMT1 |
| (<<) DNM1L → FERMT1 |
| (<<) DUSP4 → FERMT1 |
| (<<) DUSP7 → FERMT1 |
| (<<) FAM136A → FERMT1 |
| (<<) FZD7 → FERMT1 |
| (<<) GAL → FERMT1 |
| (<<) GAPDH → FERMT1 |
| (<<) GNAQ → FERMT1 |
| (<<) KLF2 → FERMT1 |
| (<<) KLK10 → FERMT1 |
| (<<) KRT16 → FERMT1 |
| (<<) MLPH → FERMT1 |
| (<<) MMP7 → FERMT1 |
| (<<) MYC → FERMT1 |
| (<<) NFIA → FERMT1 |
| (<<) NOL9 → FERMT1 |
| (<<) NRAS → FERMT1 |
| (<<) PRDX6 → FERMT1 |
| (<<) RAB7B → FERMT1 |
| (<<) RRP9 → FERMT1 |
| (<<) SERPINB5 → FERMT1 |
| (<<) SPDEF → FERMT1 |
| (<<) TMEM158 → FERMT1 |
| (<<) TMEM45B → FERMT1 |
| (<<) TRERF1 → FERMT1 |
| (<<) TTC9 → FERMT1 |
| (<<) WNT5B → FERMT1 |
| Downstream (Children) |
|---|
| FERMT1 → ALPP (>>) |
| FERMT1 → CD3EAP (>>) |
| FERMT1 → FOXQ1 (>>) |
| FERMT1 → IGFBP2 (>>) |
| FERMT1 → KRT5 (>>) |
| FERMT1 → PYGB (>>) |
| FERMT1 → RPS6KA5 (>>) |
| FERMT1 → SOX2 (>>) |
| FERMT1 → SULT4A1 (>>) |
| FERMT1 → TCEAL1 (>>) |
| FERMT1 → TMCC3 (>>) |
